Johannes Breyer Selected Research

Johannes Breyer Research Topics

Disease

25	Neoplasms (Cancer) 04/2023 - 01/2014
20	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 05/2016
19	Carcinoma (Carcinomatosis) 01/2023 - 01/2014
17	Non-Muscle Invasive Bladder Neoplasms 02/2024 - 11/2016
5	Neoplasm Metastasis (Metastasis) 04/2023 - 01/2019
2	Pathologic Constriction (Stenosis) 03/2024 - 08/2023
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2023 - 01/2019
2	Thrombosis (Thrombus) 03/2023 - 01/2019
2	Lymphocele 02/2021 - 01/2021
2	Margins of Excision 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 09/2018
2	Lymphatic Metastasis 01/2019 - 12/2018
2	Breast Neoplasms (Breast Cancer) 09/2017 - 07/2017
2	Carcinoma in Situ 03/2017 - 01/2017
1	Pathologic Dilatation (Ectasia) 03/2024
1	Hyperplasia 08/2023
1	Urethral Stricture 08/2023
1	Hematuria 08/2023
1	Urinary Retention 08/2023
1	Sarcopenia 03/2023
1	Obesity 01/2020
1	Penile Neoplasms (Penile Cancer) 09/2019
1	Testicular Neoplasms (Testicular Cancer) 01/2019
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 09/2018
1	Disease Progression 07/2017
1	Hypoxia (Hypoxemia) 10/2013

Drug/Important Bio-Agent (IBA)

18	Messenger RNA (mRNA)IBA 04/2023 - 11/2016
8	Phenobarbital (Luminal)FDA Link 04/2023 - 03/2017
7	ParaffinIBA 01/2019 - 11/2016
7	Formaldehyde (Formol)FDA Link 01/2019 - 11/2016
5	Proteins (Proteins, Gene)FDA Link 04/2023 - 03/2017
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2017
4	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
3	Androgen Receptors (Androgen Receptor)IBA 06/2021 - 06/2017
3	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2021 - 01/2018
3	Cadherins (E-Cadherin)IBA 01/2019 - 05/2016
3	RNA (Ribonucleic Acid)IBA 09/2018 - 01/2018
2	B7-H1 AntigenIBA 01/2023 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 09/2019
2	PlatinumIBA 06/2022 - 01/2020
2	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2021 - 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 08/2023
1	MicroRNAs (MicroRNA)IBA 03/2023
1	Cytotoxins (Cytolysins)IBA 01/2023
1	InterferonsIBA 01/2023
1	MethyltransferasesIBA 01/2023
1	Decitabine FDA Link 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	enfortumab vedotinIBA 01/2023
1	vinflunineIBA 06/2022
1	Cisplatin (Platino)FDA LinkGeneric 06/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Estrogen Receptor alphaIBA 01/2022
1	cyclopropapyrroloindoleIBA 11/2021
1	Protein Kinases (Protein Kinase)IBA 07/2020
1	Programmed Cell Death 1 ReceptorIBA 01/2020
1	SteroidsIBA 02/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2019
1	Hematoxylin (Haematoxylon)IBA 01/2019
1	CateninsIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Forkhead Box Protein M1IBA 01/2019
1	atezolizumabIBA 01/2019
1	AntigensIBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 12/2018
1	Aquaporins (Water Channels)IBA 09/2018
1	Fibroblast Growth Factor 3IBA 01/2018
1	Hormones (Hormone)IBA 09/2017
1	Aquaporin 3IBA 01/2017
1	SurvivinIBA 05/2016
1	Oxygen (Dioxygen)IBA 10/2013
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 10/2013

Therapy/Procedure

14	Cystectomy 02/2024 - 01/2014
13	Therapeutics 06/2022 - 09/2017
5	Immunotherapy 01/2023 - 10/2016
3	Transurethral Resection of Bladder 02/2024 - 07/2017
3	Drug Therapy (Chemotherapy) 06/2022 - 07/2017
3	Prostatectomy (Retropubic Prostatectomy) 02/2021 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 02/2021 - 01/2021
1	Stents 03/2024
1	Neoadjuvant Therapy 01/2024
1	Transurethral Resection of Prostate (TURP) 08/2023
1	Nephroureterectomy 01/2023
1	Urinary Diversion (Ileal Conduit) 01/2023
1	Salvage Therapy 01/2022
1	Aftercare (After-Treatment) 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Intravesical Administration 01/2019